CASI PHARMACEUTICALS, INC. Debt Instrument, Convertible, Beneficial Conversion Feature
CASI PHARMACEUTICALS, INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $7.06 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-21.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2014-03-21
- CASI PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2012-06-30 was $7.06M.
- CASI PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2012 was $7.06M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|
| 2012-12-31 | $7.06M 10-K · filed 2014-03-21 | |
| 2012-06-30 | $7.06M 10-Q · filed 2013-08-14 |